Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

DDianthus Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
D

Dianthus Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

SellBuy
DateNameTitleSharesValueTransactionSource
Sep 17, 2026CARR EDWARDCHIEF ACCOUNTING OFFICER20,000Common Stock—Sell
Sep 17, 2026CARR EDWARDCHIEF ACCOUNTING OFFICER20,000Common Stock—Option exercise
Sep 1, 2026Randhawa SimratEVP, Head of R&D23,124Common Stock—Sell
Sep 1, 2026Randhawa SimratEVP, Head of R&D23,124Common Stock—Option exercise
Aug 19, 2026Read SimonDirector2,778Common Stock—Sell
Aug 19, 2026Read SimonDirector2,778Common Stock—Option exercise
Aug 13, 2026Veness Adam MSVP, General Counsel and Sec.15,000Common Stock—Option exercise
Aug 10, 2026Read SimonDirector2,777Common Stock—Sell
Aug 10, 2026Read SimonDirector2,777Common Stock—Option exercise
Aug 10, 2026Veness Adam MSVP, General Counsel and Sec.16,167Common Stock—Sell
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions